Enaltus, a portfolio company of HealthEdge Investment Partners, has acquired skincare product manufacturer Mitchell-Vance Laboratories. Based in Connecticut, Mitchell-Vance develops over-the-counter, topical silicone scar treatments that are sold across more than 20,000 retailers in the United States. It will fold into Enaltus' product line, which includes a silicone scar treatment available in spray format and a skincare treatment for pregnant women, new mothers and babies.
